ATLAS is a joint PhD program by BioNTech and TRON (Translational Oncology Mainz), which are the leading immunotherapy institutions. Their joint international PhD program is seeking talented graduates as junior researchers from all nations.
Their PhD program focuses on translational medicine with experienced faculties, they provide a supportive environment for the scholars to conduct cutting-edge research projects.
ATLAS is offering 9 PhD positions in biology, life science, biochemistry, chemistry, medicine, and computer science or related areas.
Benefits of joining ATLAS
1. Collaborative interdisciplinary research between academia and pharmaceutical
2. Opportunity to publish your research work in top journals.
3. Doctoral degree from their parenting university
Who can apply?
- You should hold an M.Sc. degree or equivalent.
- You should have a strong passion for science.
- You are able to work well in an international, multi-disciplinary team and also capable of working independently.
- Professional proficiency in both written and spoken English]
Read carefully the instructions before applying.
Also Check: The University of Edinburgh, Scotland – PhD Openings – September 2023
Projects offered
| Project Number | Title of the project | Unit/Location |
|---|---|---|
| P01 | Targeting metastasizing tumor cells for the prevention of metastasis (MTC-target) | Therapeutic cardiology (Mainz, Germany) |
| P02 | RNA-based modulation of iPSC-derived cardiomyocytes for heart repair (RiPS-Cardio) | Therapeutic cardiology (Mainz, Germany) |
| P03 | Functional characterization of a novel uveal melanoma target | Expression and cell biology (Mainz, Germany) |
| P04 | Metabolism Directed Cancer Immunotherapy (MERCI) | Immunotherapies and Preclinical Research: Cancer Vaccines (Mainz, Germany) |
| P05 | Development of the circular RNA platform for protein expression | RNA Optimization & Internal Contract Synthesis (Mainz, Germany) |
| P06 | Generation and engineering of a mRNA-encoded broadly neutralizing antibody cocktail against HIV | BiMAB & IDV (Mainz, Germany) |
| P07 | Whole-Genome Sequencing and individualised cancer treatment | Bioinformatics (Mainz, Germany) |
| P08 | Development of an mRNA firetruck to promote multi-targeted individualized mRNA therapy for chronic pain recovery | Inflammation and Tissue Damage (Mainz, Germany) |
| P09 | Optimizing mRNA sequence design by combining data mining from nature with novel algorithmic approaches (OptiRNA) | RNA Biochemistry and CMC Development (Mainz, Germany) |
Deadline: October 31st 2023
Interviews: Pre-selected candidates will be invited to Mainz, Germany for two-day interviews
Published: 18-September-2023
Updated: 19-September-2023, 23:11
